CWCarlijn J. M. Wibbelink

Carlijn J. M. Wibbelink

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Carlijn J. M. Wibbelink has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Burden of Disease of Treatment‐Seeking Patients With a Cluster‐C Personality Disorder in the Netherlands; Quality of Life, Functioning, and Societal Costs

    by Iuno Z. Groot, Arnoud Arntz, Carlijn J. M. Wibbelink, Bas Verhoeven, Nathan R. Bachrach, Silvia M. A. A. Evers

    Cluster‐C personality disorders (PDs) are common in the general population but often overlooked in scientific research and clinical practice. An important step to increase awareness for timely diagnosis and treatment of cluster‐C PDs is to investigate the burden of disease in terms of quality of life (QoL), daily functioning and the associated costs to society. In addition, a comparison between these patients and a control group can give insight into (1) the actual societal costs that are associated to cluster‐C PD problems and (2) potential societal savings to be made from therapeutic interventions. This study included a total of 375 treatment seeking individuals from 10 mental health sites for outpatient treatment in the Netherlands and 104 individuals without severe mental health issues from the general population. Both QoL (EQ‐5D‐5L and the MHQoL‐7D) and general functioning (WHODAS) were assessed as well as a comprehensive cost‐interview to measure relevant costs considering a societal perspective. Results indicate that individuals with a cluster‐C PD have severely impaired QoL and functioning compared to the control group. The annual costs associated with cluster‐C PD were estimated ranging from €27,355 to €60,454 per patient per year depending on the valuation method used. These costs equate 2.8–4.2 times more than those of control group. Looking at the subgroup in cluster‐C PD, no differences in QoL, functioning or societal costs were found between individuals with avoidant, dependent and obsessive‐compulsive PD. Overall, the findings advocate for more financial resources to study, prevent and treat cluster‐C PDs.


  • Open Access

    Psychometric Properties of the Dutch Version of the Dialectical Behavior Therapy Ways of Coping Checklist (DBT‐WCCL)

    by Carlijn J. M. Wibbelink, Roland Sinnaeve, Lindy‐Lou Boyette, Arnoud Arntz, Jan H. Kamphuis

    Dialectical behavior therapy (DBT) is an extensively studied treatment for borderline personality disorder (BPD), with skills use being one of the hypothesized mechanisms of change. Research has previously been hindered by the absence of an appropriate tool to measure skills use, leading to the development of the DBT Ways of Coping Checklist (DBT‐WCCL). The DBT‐WCCL aims to assess DBT skills use (DSS) as well as dysfunctional coping (DCS), which can be divided into dysfunctional coping in general (DCS1) and blaming others (DCS2). This study evaluated the Dutch version of the DBT‐WCCL by examining (1) the dimensional structure and measurement invariance across BPD and non‐clinical samples, (2) psychometric properties (reliability and validity), and (3) sensitivity to change. A total of 204 participants diagnosed with BPD and 103 non‐clinical controls completed the Dutch DBT‐WCCL along with instruments assessing emotion regulation and BPD manifestations. First, when including all DBT‐WCCL items, the hypothesized two‐factor and three‐factor models were not tenable due to substantial content overlap. When factor analyses included only items representing DBT skills or dysfunctional coping, support was found for three subscales (DSS, DCS1, and DCS2). Partial measurement invariance was established only for the DSS subscale. Reliability and known‐group validity were satisfactory for all scales, while inconclusive results were found for the concurrent validity of the DSS subscale. Finally, the DBT‐WCCL proved to be sensitive to change. In conclusion, our findings largely support the use of the Dutch DBT‐WCCL, but warrant caution when comparing samples on dysfunctional coping. Trial Registration: The BOOTS study was registered in the Overview of Medical Research in the Netherlands (NL‐OMON21337).

  • Open Access

    Efficient screening and outcome assessment for borderline personality disorder: A psychometric evaluation of the uBPDc

    by Carlijn J.M. Wibbelink, Jan H. Kamphuis, Marieke Effting, Roland Sinnaeve, Michiel Boog, Eliane C.P. Dek, Arnoud Arntz


  • Open Access

    Burden of Disease of Borderline Personality Disorder: A Comprehensive Evaluation of Quality of Life and Societal Cost of Illness

    by Carlijn J. M. Wibbelink, Arnoud Arntz, Jan H. Kamphuis, Iuno Z. Groot, Roland Sinnaeve, Silvia M. A. A. Evers

    Information on the burden of disease, including quality of life (QoL) and societal costs, of borderline personality disorder (BPD) is crucial, as healthcare policymakers consider the burden of disease when setting priorities for treatment reimbursement. We conducted a comprehensive evaluation of the burden of disease of BPD by estimating annual costs from a societal perspective using a bottom‐up approach and distinguishing between costs primarily related to psychological and somatic problems. QoL was determined using a generic QoL measure (EQ‐5D five‐level version [EQ‐5D‐5L]) as well as a measure specifically designed for individuals with psychological problems (Mental Health Quality of Life seven‐dimensional questionnaire [MHQoL‐7D]). Additionally, societal costs and QoL were compared with a comparison group. Data from 204 Dutch treatment‐seeking outpatients diagnosed with BPD and 86 individuals without severe psychological problems were analyzed. The results indicated a severely impaired QoL (EQ‐5D‐5L: 0.51, MHQoL‐7D: 0.24) combined with substantial societal costs (average total €35,038 per year) for BPD outpatients, markedly different from the comparison group. Societal costs of BPD were primarily attributable to psychological problems, with costs in other sectors as the main cost driver. The BPD group incurred higher costs for most patient and family cost items and cost items in other sectors, whereas differences in healthcare costs were limited to outpatient psychiatric treatment, consultations with general practitioners, emergency care, and social work. The high economic burden, along with the low QoL, suggests that increased treatment reimbursement for BPD would benefit both patients and society at large.Trial Registration: The BOOTS study was registered in the Overview of Medical Research in the Netherlands (NL‐OMON21337), formerly known as the Netherlands Trial Register.


  • Using the Minnesota Multiphasic Personality Inventory–2 restructured form to predict functioning after treatment for borderline personality disorder: A machine learning approach.

    by Carlijn J. M. Wibbelink, Martin Sellbom, Raoul P. P. P. Grasman, Arnoud Arntz, Roland Sinnaeve, Jan H. Kamphuis

    Insight into predictors of functioning after treatment for borderline personality disorder (BPD) is limited, despite growing recognition that more focus on other aspects of recovery, especially psychosocial functioning, is warranted. The present study explored the utility of a widely used omnibus assessment instrument, the Minnesota Multiphasic Personality Inventory-2 Restructured Form (MMPI-2-RF), to predict change in functioning during treatment for BPD. Data were obtained from a randomized clinical trial into the effectiveness of 2-year evidence-based treatment for BPD (dialectical behavior therapy or schema therapy) among 130 participants diagnosed with BPD. Different machine learning algorithms, including elastic net regression (ENR), random forest, gradient boosting machine, and extreme gradient boosting, were implemented using nested cross-validation. The ENR model had an average explained variance of 42%. A combination of baseline functioning and four MMPI-2-RF scales emerged as key predictors of change in functioning. Baseline functioning was the most important predictor, with lower initial functioning levels related to more improvement. Higher scores on ideas of persecution, somatic complaints, family problems, and disconstraint were associated with less improvement in functioning. Given the risk of overfitting and the lack of an independent data set, future research should focus on the replicability and generalizability of the findings, as well as clarifying the underlying mechanisms. Our study serves as a first step in identifying patients at risk of poor functional outcome after treatment for BPD. (PsycInfo Database Record (c) 2025 APA, all rights reserved).


  • Open Access

    Group schema therapy for cluster‐C personality disorders: A multicentre open pilot study

    by Carlijn J. M. Wibbelink, Anne‐Sophie S. M. Venhuizen, Raoul P. P. P. Grasman, Nathan Bachrach, Charlotte van Den Hengel, Sandy Hudepohl, Liselotte Kunst, Hinde de Lange, Mark A. Louter, Suzy J. M. A. Matthijssen, et al.

    Background: Group schema therapy (GST) is increasingly popular as a treatment for personality disorders (PDs), including Cluster‐C PDs. Individual ST has proven to be effective for Cluster‐C PD patients, while the evidence for GST is limited. This study aimed to investigate the effectiveness of GST for Cluster‐C PD. Moreover, differences between the specific Cluster‐C PDs (avoidant PD, dependent PD and obsessive‐compulsive PD) were explored.Methods: A multicentre open trial was conducted, including 137 patients with a Cluster‐C PD (avoidant PD: n = 107, dependent PD: n = 11 and obsessive‐compulsive PD: n = 19). Patients received 30 weekly GST sessions with a maximum of 180 min of individual ST and five optional monthly booster sessions. Outcome measures including Cluster‐C PD severity, general psychopathological symptoms, quality of life, functional impairment, happiness, PD‐related beliefs, self‐esteem, self‐ideal discrepancy, schemas and schema modes were assessed at baseline until 2‐year follow‐up with semi‐structured interviews and self‐report measures. Change over time and differences between the specific Cluster‐C PDs were analysed with mixed regression analyses.Results: The outcome measures showed significant improvements for all Cluster‐C PDs, with medium to large effect sizes after 2 years. A treatment dropout rate of 11.7% was found. There were some indications for differences between the Cluster‐C PDs in severity at baseline, change trajectories and effectiveness of GST.Conclusions: This study demonstrated that GST is a promising treatment for Cluster‐C PDs. The following step is a randomized controlled trial to further document the (cost‐)effectiveness of GST.


  • Open Access

    Addressing Dependency in Meta-Analysis: A Companion to Assink and Wibbelink (2016)

    by Mark Assink, Carlijn Wibbelink

    This research note elaborates on addressing dependency in effect size data and serves as a companion to our tutorial on fitting three-level meta-analytic models in R (Assink & Wibbelink, 2016). We provide a description of effect size and sampling error dependency, explain how both the multilevel and multivariate meta-analytic models handle these types of dependency, and discuss the role of alternative methods in addressing dependency in effect size data, including approximating a variance-covariance matrix and applying a cluster-robust inference method. These alternative methods are illustrated with example R code that builds upon the effect size dataset that we presented and analyzed in our tutorial. We conclude that more simulation studies are needed to provide clearer guidelines for modeling dependency in effect size data and urge statisticians to make the available technical literature further accessible to applied researchers.


  • A Multilevel Meta-Analysis of Dynamic Risk Factors for Emerging Adults who Abuse their Parents

    by Simone B. Close, Joan E. van Horn, Carlijn J. M. Wibbelink

    Purpose Even though five to 11% of child-to-parent abuse (CPA) perpetrators are emerging adults (age 18–23 years), relevant risk factors underlying CPA in this group are understudied. Method A multilevel meta-analysis was performed on nine studies (450 effect sizes, N = 1,043), comprising eight static (e.g., age and gender of perpetrator) and dynamic (e.g., substance abuse, financial problems) risk factors. Results Emerging adults who fell victim of domestic violence, or had antisocial cognitions, authority problems, or empathy problems displayed CPA more often. Moderator analyses revealed that the relation between gender of perpetrator and CPA was moderated by gender of victim (p = .033) and CPA type (p = .021). Gender of victim (p < .001) also moderated the relationship between single-parent household and CPA. Finally, the relation between witness to DV and CPA was moderated by age (p = .007). Conclusions This was the first multilevel meta-analysis focusing exclusively on CPA displayed by emerging adults. The results can be used as a basis for further research into relevant risk factors for CPA in this group and hopefully contribute to the development of health care interventions to reduce chances of CPA occurring.


  • Open Access

    Towards optimal treatment selection for borderline personality disorder patients (BOOTS): a study protocol for a multicenter randomized clinical trial comparing schema therapy and dialectical behavior therapy

    by Carlijn J. M. Wibbelink, Arnoud Arntz, Raoul P. P. P. Grasman, Roland Sinnaeve, Michiel Boog, Odile M. C. Bremer, Eliane C. P. Dek, Sevinç Göral Alkan, Chrissy James, Annemieke M. Koppeschaar, et al.

    Background: Specialized evidence-based treatments have been developed and evaluated for borderline personality disorder (BPD), including Dialectical Behavior Therapy (DBT) and Schema Therapy (ST). Individual differences in treatment response to both ST and DBT have been observed across studies, but the factors driving these differences are largely unknown. Understanding which treatment works best for whom and why remain central issues in psychotherapy research. The aim of the present study is to improve treatment response of DBT and ST for BPD patients by a) identifying patient characteristics that predict (differential) treatment response (i.e., treatment selection) and b) understanding how both treatments lead to change (i.e., mechanisms of change). Moreover, the clinical effectiveness and cost-effectiveness of DBT and ST will be evaluated. Methods: The BOOTS trial is a multicenter randomized clinical trial conducted in a routine clinical setting in several outpatient clinics in the Netherlands. We aim to recruit 200 participants, to be randomized to DBT or ST. Patients receive a combined program of individual and group sessions for a maximum duration of 25 months. Data are collected at baseline until three-year follow-up. Candidate predictors of (differential) treatment response have been selected based on the literature, a patient representative of the Borderline Foundation of the Netherlands, and semi-structured interviews among 18 expert clinicians. In addition, BPD-treatment-specific (ST: beliefs and schema modes; DBT: emotion regulation and skills use), BPD-treatment-generic (therapeutic environment characterized by genuineness, safety, and equality), and non-specific (attachment and therapeutic alliance) mechanisms of change are assessed. The primary outcome measure is change in BPD manifestations. Secondary outcome measures include functioning, additional self-reported symptoms, and well-being. Discussion: The current study contributes to the optimization of treatments for BPD patients by extending our knowledge on “Which treatment – DBT or ST – works the best for which BPD patient, and why?”, which is likely to yield important benefits for both BPD patients (e.g., prevention of overtreatment and potential harm of treatments) and society (e.g., increased economic productivity of patients and efficient use of treatments). Trial registration: Netherlands Trial Register, NL7699, registered 25/04/2019 - retrospectively registered.


  • Open Access

    The effect of twice-weekly versus once-weekly sessions of either imagery rescripting or eye movement desensitization and reprocessing for adults with PTSD from childhood trauma (IREM-Freq): a study protocol for an international randomized clinical trial

    by Carlijn J. M. Wibbelink, Christopher W. Lee, Nathan Bachrach, Sarah K. Dominguez, Thomas Ehring, Saskia M. van Es, Eva Fassbinder, Sandra Köhne, Magda Mascini, Marie-Louise Meewisse, et al.

    Background: Trauma-focused treatments for posttraumatic stress disorder (PTSD) are commonly delivered either once or twice a week. Initial evidence suggests that session frequency affects treatment response, but very few trials have investigated the effect of session frequency. The present study’s aim is to compare treatment outcomes of twice-weekly versus once-weekly sessions of two treatments for PTSD related to childhood trauma, imagery rescripting (ImRs) and eye movement desensitization and reprocessing (EMDR). We hypothesize that both treatments will be more effective when delivered twice than once a week. How session frequency impacts treatment response, whether treatment type moderates the frequency effect, and which treatment type and frequency works best for whom will also be investigated. Methods: The IREM-Freq trial is an international multicenter randomized clinical trial conducted in mental healthcare centers across Australia, Germany, and the Netherlands. We aim to recruit 220 participants, who will be randomized to one of four conditions: (1) EMDR once a week, (2) EMDR twice a week, (3) ImRs once a week, or (4) ImRs twice a week. Treatment consists of 12 sessions. Data are collected at baseline until one-year follow-up. The primary outcome measure is clinician-rated PTSD symptom severity. Secondary outcome measures include self-reported PTSD symptom severity, complex PTSD symptoms, trauma-related cognitions and emotions, depressive symptoms, dissociation, quality of life, and functioning. Process measures include memory, learning, therapeutic alliance, motivation, reluctance, and avoidance. Additional investigations will focus on predictors of treatment outcome and PTSD severity, change mechanisms of EMDR and ImRs, the role of emotions, cognitions, and memory, the optimization of treatment selection, learned helplessness, perspectives of patients and therapists, the network structure of PTSD symptoms, and sudden treatment gains. Discussion: This study will extend our knowledge on trauma-focused treatments for PTSD related to childhood trauma and, more specifically, the importance of session frequency. More insight into the optimal session frequency could lead to improved treatment outcomes and less dropout, and in turn, to a reduction of healthcare costs. Moreover, the additional investigations will broaden our understanding of how the treatments work and variables that affect treatment outcome. Trial registration: Netherlands Trial Register NL6965, registered 25/04/2018.